The roles of lipids in SARS-CoV-2 viral replication and the host immune response
Author(s) -
Katherine N. Theken,
Soon Yew Tang,
Shaon Sengupta,
Garret A. FitzGerald
Publication year - 2021
Publication title -
journal of lipid research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.992
H-Index - 192
eISSN - 1539-7262
pISSN - 0022-2275
DOI - 10.1016/j.jlr.2021.100129
Subject(s) - immune system , viral replication , lipid metabolism , biology , viral entry , coronavirus , lipid signaling , virology , viral life cycle , virus , sphingolipid , lipid bilayer fusion , immunology , covid-19 , microbiology and biotechnology , inflammation , medicine , disease , biochemistry , infectious disease (medical specialty) , pathology
The significant morbidity and mortality associated with severe acute respiratory syndrome coronavirus 2 infection has underscored the need for novel antiviral strategies. Lipids play essential roles in the viral life cycle. The lipid composition of cell membranes can influence viral entry by mediating fusion or affecting receptor conformation. Upon infection, viruses can reprogram cellular metabolism to remodel lipid membranes and fuel the production of new virions. Furthermore, several classes of lipid mediators, including eicosanoids and sphingolipids, can regulate the host immune response to viral infection. Here, we summarize the existing literature on the mechanisms through which these lipid mediators may regulate viral burden in COVID-19. Furthermore, we define the gaps in knowledge and identify the core areas in which lipids offer therapeutic promise for severe acute respiratory syndrome coronavirus 2.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom